妊娠中の重度の吐き気と嘔吐の負担を評価し,それに関連する薬物治療の使用と経験:オーストラリアの消費者調査
Loyola Wills1, Han-Fang Hsiao2, Alicia Thomas2
1College of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
PloS one
|September 3, 2025
まとめ
妊娠中の重度の吐き気 (NVP) と妊娠中症 (HG) は,女性に影響を及ぼします.
科学分野:
- 産婦人科
- 妊婦と胎児の医療
- 妊娠中の薬理学
背景:
- 妊娠中の重度の吐き気および嘔吐 (NVP) または妊娠中症 (HG) の抗嘔吐剤の使用に関する現在のデータは限られている.
- 妊娠中の女性に対する 嘔吐抑制剤の治療の経験を理解することは 治療の改善に不可欠です
研究 の 目的:
- 重度のNVPまたはHGを経験するオーストラリアの女性における抗嘔吐薬の使用パターンを調査する.
- 女性の経験と様々な反嘔吐治療の効果を調査する.
主な方法:
- 深刻なNVPやHGを持つオーストラリアの女性を対象にオンラインで全国的な調査が行われました.
- 2020年7月から9月の間に,消費者団体Hyperemesis Australiaを通じてデータ収集が行われました.
主要な成果:
- 289人の女性が反応し,50%以上が人生に重大な影響を及ぼし,62%がうつ病/不安を体験した.
- Ondansetronは最も一般的であり (91%),しばしば最初の3ヶ月で第一線薬として使用されました.
- 副作用は一般的であり,メトクロプラミドは,オダンセトロン (14%) と比較して,副作用による中止率が高かった.
- オンダンセトロン,ドキシラミン,コルチコステロイドが最も効果的であると見なされた.
- 50%は酸抑制療法,51%は補足療法/代替療法を使用した.
結論:
- NVP/ HGの抗嘔吐薬の使用と治療結果には大きな変動がある.
- 妊娠中の重度のNVPとHGの管理には,個別化されたケアと調整された治療戦略が不可欠です.
さらに関連する動画
関連する概念動画
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
321
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
321
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
439
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
439
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
259
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
259
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
366
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
366
Pathophysiology of Vomiting
1.1K
Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
1.1K
Assessment of the Gastrointestinal System I: Subjective Data
275
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
275


